Chimerix names new chief commercial officer
This article was originally published in Scrip
Chimerix, a biopharmaceutical company developing oral antivirals in areas of high unmet need, has appointed Linda M Richardson chief commercial officer. She will be responsible for establishing the company's commercial infrastructure and building its capabilities for the potential launch of lead compound brincidofovir. Prior to joining the Durham, North Carolina-based firm Ms Richardson was vice-president and head of the global lixisenatide franchise at Sanofi.